KNSA

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -0.24
Percentage change -0.91	%

Held by: VTI IWM VB XBI VBR VXF IWO IBB VTWO VHT

Index	RUT	P/E	-	EPS (ttm)	-0.16	Insider Own	45.63%	Shs Outstand	71.24M	Perf Week	2.97%
Market Cap	1.85B	Forward P/E	36.89	EPS next Y	0.70	Insider Trans	-1.00%	Shs Float	38.73M	Perf Month	-1.59%
Income	-10.23M	PEG	-	EPS next Q	0.03	Inst Own	50.67%	Short Float	11.75%	Perf Quarter	39.76%
Sales	338.93M	P/S	5.47	EPS this Y	-175.83%	Inst Trans	-0.13%	Short Ratio	9.64	Perf Half Y	31.36%
Book/sh	6.12	P/B	4.25	EPS next Y	564.83%	ROA	-1.99%	Short Interest	4.55M	Perf Year	53.63%
Cash/sh	3.07	P/C	8.47	EPS next 5Y	-	ROE	-2.42%	52W Range	14.12 - 27.92	Perf YTD	48.29%
Dividend Est.	-	P/FCF	61.13	EPS past 5Y	-	ROI	-2.30%	52W High	-6.84%	Beta	0.33
Dividend TTM	-	Quick Ratio	3.16	Sales past 5Y	98.80%	Gross Margin	62.19%	52W Low	84.21%	ATR (14)	1.02
Dividend Ex-Date	-	Current Ratio	3.57	EPS Y/Y TTM	-104.34%	Oper. Margin	-8.12%	RSI (14)	56.22	Volatility	4.15% 3.69%
Employees	297	Debt/Eq	0.03	Sales Y/Y TTM	20.69%	Profit Margin	-3.02%	Recom	1.00	Target Price	35.00
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	-126.32%	Payout	0.00%	Rel Volume	0.68	Prev Close	26.25
Sales Surprise	19.90%	EPS Surprise	21.98%	Sales Q/Q	51.99%	Earnings	Jul 23 BMO	Avg Volume	471.92K	Price	26.01
SMA20	1.12%	SMA50	4.01%	SMA200	27.01%	Trades		Volume	250,605	Change	-0.91%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-13-24	Initiated	Jefferies	Buy	$40
May-03-24	Initiated	Wells Fargo	Overweight	$34
Jun-29-20	Reiterated	BofA Securities	Buy	$25 → $40
Apr-01-20	Initiated	BofA/Merrill	Buy	$25
Mar-11-19	Initiated	Barclays	Overweight	$26
Dec-12-18	Reiterated	Wedbush	Outperform	$31 → $33
Jun-19-18	Initiated	JMP Securities	Mkt Outperform	$33

Aug-28-24 04:01PM	Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-05-24 09:55AM	Wall Street Analysts Believe Kiniksa Pharmaceuticals (KNSA) Could Rally 30.11%: Here's is How to Trade (Zacks)
Jul-26-24 12:00PM	Kiniksa Pharmaceuticals, Ltd. (KNSA) Is Up 0.09% in One Week: What You Should Know (Zacks)
08:50AM	Recent Price Trend in Kiniksa Pharmaceuticals (KNSA) is Your Friend, Here's Why (Zacks)
Jul-23-24 08:35AM	Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +22.91%
07:30AM	Loading…
07:30AM	Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution (GlobeNewswire)
Jul-16-24 04:01PM	Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024 (GlobeNewswire)
Jul-09-24 08:00AM	Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjogren's Disease (GlobeNewswire)
08:00AM	Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sj gren's Disease (GlobeNewswire)
Jun-24-24 08:00AM	Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent Pericarditis (GlobeNewswire)
Jun-17-24 08:30AM	Kiniksa Pharmaceuticals Sponsors American Heart Association's Addressing Recurrent Pericarditis Initiative (GlobeNewswire)
Jun-04-24 04:01PM	Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
Jun-03-24 07:00AM	Sector Spotlight: Orphan Drug Developers With Significant Upside (News Direct)
May-07-24 04:01PM	Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference (GlobeNewswire)
Apr-24-24 09:00AM	Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:53AM	Loading…
Apr-23-24 11:53AM	KNSA Stock Earnings: Kiniksa Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:53AM	Kiniksa Pharmaceuticals Ltd (KNSA) Q1 2024 Earnings Overview: Surpasses Revenue Forecasts (GuruFocus.com)
08:40AM	Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
08:36AM	Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises (MT Newswires)
07:30AM	Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution (GlobeNewswire)
Apr-16-24 04:01PM	Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024 (GlobeNewswire)
Apr-02-24 07:30AM	Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart (GlobeNewswire)
Mar-01-24 09:55AM	Does Kiniksa Pharmaceuticals, Ltd. (KNSA) Have the Potential to Rally 32.45% as Wall Street Analysts Expect? (Zacks)
Feb-29-24 11:33PM	Chief Medical Officer John Paolini Sells 10,156 Shares of Kiniksa Pharmaceuticals Ltd (KNSA) (GuruFocus.com)
12:00PM	Are You Looking for a Top Momentum Pick? Why Kiniksa Pharmaceuticals, Ltd. (KNSA) is a Great Choice (Zacks)
09:21AM	Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 08:50AM	Kiniksa Pharmaceuticals, Ltd. (KNSA) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
08:40AM	Kiniksa Pharmaceuticals, Ltd. (KNSA) Q4 Earnings and Revenues Surpass Estimates (Zacks)
07:52AM	Kiniksa Pharmaceuticals Ltd (KNSA) Reports Strong Revenue Growth in Q4 and Full-Year 2023 (GuruFocus.com)
07:30AM	Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution (GlobeNewswire)
04:01PM	Loading…
Feb-21-24 04:01PM	Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024 (GlobeNewswire)
Feb-12-24 09:55AM	Wall Street Analysts Predict a 38.07% Upside in Kiniksa Pharmaceuticals, Ltd. (KNSA): Here's What You Should Know (Zacks)
08:50AM	Kiniksa Pharmaceuticals, Ltd. (KNSA) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Jan-23-24 09:55AM	How Much Upside is Left in Kiniksa Pharmaceuticals, Ltd. (KNSA)? Wall Street Analysts Think 43.93% (Zacks)
08:50AM	Recent Price Trend in Kiniksa Pharmaceuticals, Ltd. (KNSA) is Your Friend, Here's Why (Zacks)
Jan-09-24 08:46AM	Is Kiniksa Pharmaceuticals (KNSA) Stock a Solid Choice Right Now? (Zacks)
Jan-04-24 07:30AM	Kiniksa Pharmaceuticals Provides Corporate Update (GlobeNewswire)
Jan-02-24 04:01PM	Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +5.64% +7.83%
Dec-23-23 09:00AM	Chief Accounting Officer Michael Megna Sells 9,316 Shares of Kiniksa Pharmaceuticals Ltd (KNSA) (GuruFocus.com)
Dec-15-23 02:30PM	The 3 Most Undervalued Biotech Stocks to Buy in December (InvestorPlace) +5.51%
Nov-24-23 02:05PM	Kiniksa Pharmaceuticals (KNSA) Up 14.7% YTD: Here's How (Zacks)
Nov-20-23 09:55AM	Wall Street Analysts See a 70.27% Upside in Kiniksa Pharmaceuticals, Ltd. (KNSA): Can the Stock Really Move This High? (Zacks)
Nov-09-23 10:01PM	7 Underappreciated Biotech Stocks to Pick Up on the Cheap (InvestorPlace) -5.83%
Nov-01-23 08:27AM	Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-31-23 10:48PM	Q3 2023 Kiniksa Pharmaceuticals Ltd Earnings Call (Thomson Reuters StreetEvents)
08:50AM	Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution (GlobeNewswire)
Oct-24-23 04:01PM	Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023 (GlobeNewswire)
Oct-20-23 12:08PM	12 Cheap Biotech Stocks Smart Investors Are Piling Into (Insider Monkey)
Sep-29-23 12:43PM	25 Biggest Stocks with Negative Beta (Insider Monkey)
Aug-27-23 08:40AM	13 NASDAQ Stocks with Lowest PE Ratios That May Not Be Value Traps (Insider Monkey)
Aug-22-23 08:14AM	11 Most Undervalued Biotech Stocks to Buy According to Analysts (Insider Monkey)
Aug-18-23 09:04PM	HHLR ADVISORS, LTD. Increases Stake in Kiniksa Pharmaceuticals Ltd (GuruFocus.com)
Aug-10-23 10:33PM	Fairmount Funds Management LLC Acquires New Stake in Kiniksa Pharmaceuticals Ltd (GuruFocus.com)
Aug-07-23 06:14AM	Investing in Kiniksa Pharmaceuticals (NASDAQ:KNSA) a year ago would have delivered you a 41% gain (Simply Wall St.)
Jul-25-23 10:05PM	Q2 2023 Kiniksa Pharmaceuticals Ltd Earnings Call (Thomson Reuters StreetEvents) +30.39%
01:06PM	Why Shares of Kiniksa Pharmaceuticals Jumped Tuesday (Motley Fool)
08:45AM	Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution (GlobeNewswire)
Jul-24-23 08:31AM	Illumina (ILMN) Soars 3.4%: Is Further Upside Left in the Stock? (Zacks)
Jul-18-23 04:01PM	Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023 (GlobeNewswire)
Jul-17-23 08:00AM	Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023 (GlobeNewswire) +5.02%
Jul-04-23 08:24PM	3 Small-Cap Stocks That Are Worth the Gamble (InvestorPlace)
Jun-06-23 04:01PM	Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference (GlobeNewswire)
May-03-23 06:14AM	Kiniksa Pharmaceuticals First Quarter 2023 Earnings: Beats Expectations (Simply Wall St.) +8.34%
May-02-23 08:45AM	Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +14.66%
07:30AM	Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Portfolio Execution (GlobeNewswire)
May-01-23 04:01PM	Kiniksa Pharmaceuticals to Report First Quarter 2023 Financial Results on May 2, 2023 (GlobeNewswire)
Apr-09-23 09:21AM	Could The Market Be Wrong About Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Given Its Attractive Financial Prospects? (Simply Wall St.)
Apr-05-23 01:40PM	7 Thrilling Biotech Stocks for Aggressive Investors to Buy (InvestorPlace)
Mar-31-23 09:35AM	After Plunging -13.29% in 4 Weeks, Here's Why the Trend Might Reverse for Kiniksa Pharmaceuticals, Ltd. (KNSA) (Zacks)
Mar-30-23 02:20PM	7 Small-Cap Stocks to Buy for Explosive Growth Potential (InvestorPlace)
Mar-29-23 10:13AM	12 Cheap Healthcare Stocks to Buy in 2023 (Insider Monkey)
Mar-27-23 12:04PM	HCA Healthcare (HCA) Expands in Kansas With a Medical Plaza (Zacks)
Mar-23-23 02:25PM	7 Dirt-Cheap Stocks Sitting in the Sweet Spot (InvestorPlace)
Mar-03-23 06:57PM	The Top 7 Growth Stocks in Biotech (InvestorPlace)
Feb-28-23 11:25AM	Kiniksa Pharmaceuticals, Ltd. (KNSA) Beats Q4 Earnings and Revenue Estimates (Zacks)
08:00AM	Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Portfolio Execution (GlobeNewswire)
Feb-27-23 04:01PM	Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on February 28, 2023 (GlobeNewswire)
11:47AM	Further weakness as Kiniksa Pharmaceuticals (NASDAQ:KNSA) drops 9.0% this week, taking three-year losses to 32% (Simply Wall St.)
Feb-23-23 10:50AM	13 High Growth Pharma Stocks that are Profitable (Insider Monkey)
Jan-25-23 02:52AM	Allogene Therapeutics (ALLO) Soars 15.7%: Is Further Upside Left in the Stock? (Zacks)
Jan-21-23 04:51PM	10 Best Healthcare Stocks For the Long Term (Insider Monkey)
Jan-09-23 08:00AM	Kiniksa Pharmaceuticals Provides Corporate and Portfolio Update (GlobeNewswire) -7.79%
Jan-03-23 04:01PM	Kiniksa Pharmaceuticals to Present at 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-30-22 04:01PM	Kiniksa Pharmaceuticals to Present at Bank of America Securities 2022 Biotech SMID Cap Conference (GlobeNewswire)
Nov-23-22 04:01PM	Kiniksa Pharmaceuticals to Present at Evercore ISI 5th Annual HealthCONx Conference (GlobeNewswire)
Nov-10-22 09:40AM	Are Medical Stocks Lagging Kiniksa Pharmaceuticals (KNSA) This Year? (Zacks)
Nov-07-22 09:55AM	Wall Street Analysts Predict a 73% Upside in Kiniksa Pharmaceuticals, Ltd. (KNSA): Here's What You Should Know (Zacks) +9.68%
08:50AM	Recent Price Trend in Kiniksa Pharmaceuticals, Ltd. (KNSA) is Your Friend, Here's Why (Zacks)
Nov-01-22 09:15AM	Kiniksa Pharmaceuticals, Ltd. (KNSA) Beats Q3 Earnings Estimates (Zacks) +12.08%
08:00AM	Kiniksa Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-31-22 04:01PM	Kiniksa Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 1, 2022 (GlobeNewswire)
Oct-24-22 09:40AM	Is Geron (GERN) Outperforming Other Medical Stocks This Year? (Zacks)
Oct-05-22 08:50AM	What Makes Kiniksa Pharmaceuticals, Ltd. (KNSA) a Good Fit for "Trend Investing" (Zacks)
Sep-21-22 12:00PM	Kiniksa Pharmaceuticals, Ltd. (KNSA) Upgraded to Buy: Here's Why (Zacks)
Sep-20-22 10:30AM	Kiniksa Pharmaceuticals' (NASDAQ:KNSA) investors will be pleased with their 20% return over the last three years (Simply Wall St.) +6.52%
Sep-12-22 08:30AM	Kiniksa Pharmaceuticals Announces Closing of Global License Agreement with Genentech for Vixarelimab (GlobeNewswire)
Aug-22-22 09:55AM	Can Kiniksa Pharmaceuticals, Ltd. (KNSA) Climb 106% to Reach the Level Wall Street Analysts Expect? (Zacks)
Aug-05-22 09:55AM	Wall Street Analysts See an 114% Upside in Kiniksa Pharmaceuticals, Ltd. (KNSA): Can the Stock Really Move This High? (Zacks) +14.71%

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Tessari Eben	CHIEF OPERATING OFFICER	Sep 02 '24	Option Exercise	0.00	1,964	0	125,052	Sep 04 08:53 PM
Paolini John F.	CHIEF MEDICAL OFFICER	Sep 03 '24	Option Exercise	1.88	60,692	113,809	112,730	Sep 04 08:52 PM
Paolini John F.	CHIEF MEDICAL OFFICER	Sep 03 '24	Sale	26.12	60,692	1,584,991	52,038	Sep 04 08:52 PM
Moat Ross	CHIEF COMMERCIAL OFFICER	Sep 03 '24	Option Exercise	10.95	68,506	750,192	90,242	Sep 04 08:42 PM
Moat Ross	CHIEF COMMERCIAL OFFICER	Sep 03 '24	Sale	26.12	68,506	1,789,190	21,736	Sep 04 08:42 PM
Moat Ross	Officer	Sep 03 '24	Proposed Sale	26.12	68,506	1,789,288		Sep 03 05:17 PM
Paolini John F.	Officer	Sep 03 '24	Proposed Sale	26.12	90,217	2,356,351		Sep 03 05:16 PM
Tessari Eben	CHIEF OPERATING OFFICER	Aug 27 '24	Option Exercise	1.59	10,000	15,900	137,411	Aug 29 04:36 PM
Tessari Eben	CHIEF OPERATING OFFICER	Aug 27 '24	Sale	26.91	17,500	470,925	119,911	Aug 29 04:36 PM
Tessari Eben	Officer	Aug 27 '24	Proposed Sale	26.91	17,500	470,904		Aug 27 05:17 PM
Patel Sanj K	CHAIRMAN & CEO	Jul 23 '24	Option Exercise	1.59	136,124	216,437	199,136	Jul 25 04:33 PM
Patel Sanj K	CHAIRMAN & CEO	Jul 23 '24	Sale	25.65	136,124	3,491,947	63,012	Jul 25 04:33 PM
Ragosa Mark	CHIEF FINANCIAL OFFICER	Jul 23 '24	Option Exercise	11.10	24,248	269,153	43,501	Jul 25 04:32 PM
Ragosa Mark	CHIEF FINANCIAL OFFICER	Jul 23 '24	Sale	24.79	24,248	601,108	19,253	Jul 25 04:32 PM
Paolini John F.	CHIEF MEDICAL OFFICER	Jul 23 '24	Option Exercise	1.86	22,000	40,920	69,803	Jul 25 04:31 PM
Paolini John F.	CHIEF MEDICAL OFFICER	Jul 23 '24	Sale	26.32	22,000	578,966	47,803	Jul 25 04:31 PM
Patel Sanj K	CHAIRMAN & CEO	Mar 07 '24	Sale	21.02	65,012	1,366,552	0	Mar 11 07:05 PM
Patel Sanj K	CHAIRMAN & CEO	Mar 04 '24	Sale	21.49	12,742	273,834	70,594	Mar 06 05:37 PM
Patel Sanj K	CHAIRMAN & CEO	Mar 06 '24	Sale	21.00	5,582	117,222	65,012	Mar 06 05:37 PM
Tessari Eben	CHIEF OPERATING OFFICER	Mar 01 '24	Option Exercise	1.59	656	1,043	124,036	Mar 05 04:34 PM
Tessari Eben	CHIEF OPERATING OFFICER	Mar 01 '24	Sale	22.03	1,189	26,194	122,847	Mar 05 04:34 PM
Paolini John F.	CHIEF MEDICAL OFFICER	Mar 01 '24	Option Exercise	1.86	18,844	35,050	62,736	Mar 05 04:31 PM
Paolini John F.	CHIEF MEDICAL OFFICER	Mar 01 '24	Sale	21.77	18,844	410,234	44,892	Mar 05 04:31 PM
Megna Michael R	CHIEF ACCOUNTING OFFICER	Mar 01 '24	Option Exercise	10.93	9,659	105,560	27,247	Mar 01 06:26 PM
Megna Michael R	CHIEF ACCOUNTING OFFICER	Feb 28 '24	Option Exercise	8.83	5,126	45,263	22,714	Mar 01 06:26 PM
Megna Michael R	CHIEF ACCOUNTING OFFICER	Mar 01 '24	Sale	21.45	9,659	207,186	17,588	Mar 01 06:26 PM
Megna Michael R	CHIEF ACCOUNTING OFFICER	Feb 28 '24	Sale	21.79	5,126	111,696	17,588	Mar 01 06:26 PM
Paolini John F.	CHIEF MEDICAL OFFICER	Feb 27 '24	Option Exercise	1.86	10,156	18,890	55,048	Feb 29 04:26 PM
Paolini John F.	CHIEF MEDICAL OFFICER	Feb 27 '24	Sale	21.03	10,156	213,581	44,892	Feb 29 04:26 PM
Ragosa Mark	CHIEF FINANCIAL OFFICER	Jan 03 '24	Option Exercise	8.83	12,000	105,960	27,632	Jan 04 04:30 PM
Ragosa Mark	CHIEF FINANCIAL OFFICER	Jan 03 '24	Sale	20.00	12,000	240,000	15,632	Jan 04 04:30 PM
Megna Michael R	CHIEF ACCOUNTING OFFICER	Jan 02 '24	Option Exercise	13.88	16,670	231,380	33,675	Jan 04 04:30 PM
Megna Michael R	CHIEF ACCOUNTING OFFICER	Jan 02 '24	Sale	19.17	16,670	319,564	17,005	Jan 04 04:30 PM
Megna Michael R	CHIEF ACCOUNTING OFFICER	Dec 19 '23	Option Exercise	13.88	9,316	129,306	26,321	Dec 21 04:26 PM
Megna Michael R	CHIEF ACCOUNTING OFFICER	Dec 19 '23	Sale	19.13	9,316	178,215	17,005	Dec 21 04:26 PM
Paolini John F.	CHIEF MEDICAL OFFICER	Dec 07 '23	Option Exercise	1.86	28,600	53,196	73,492	Dec 11 04:20 PM
Paolini John F.	CHIEF MEDICAL OFFICER	Dec 07 '23	Sale	17.65	28,600	504,758	44,892	Dec 11 04:20 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Kiniksa Pharmaceuticals International Plc.

Upgrade your FINVIZ experience